Profil
Johan Dighed currently serves as Chief Legal Officer, General Counsel & Deputy CEO at KDventures AB since 2021.
The role at KDventures AB started in 2020.
Johan is an Independent Director at Promimic AB since 2021 and at Modus Therapeutics Holding AB since 2024.
Johan holds Director positions at KCIF Fund Management AB, KDev Oncology AB, Modus Therapeutics AB, KD Incentive AB, KDev Investments AB, PharmNovo AB, and AnaCardio AB. Formerly, Johan was Head-Legal at DSK Hyp AG.
Johan completed graduate studies at the University of Lund.
Postes actifs de Johan Dighed
| Sociétés | Poste | Début |
|---|---|---|
| KDVENTURES AB | Conseiller Juridique Général | 01/05/2020 |
| PROMIMIC AB | Directeur/Membre du Conseil | 01/01/2021 |
| MODUS THERAPEUTICS HOLDING AB | Directeur/Membre du Conseil | 01/09/2024 |
AnaCardio AB
AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Directeur/Membre du Conseil | - |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Directeur/Membre du Conseil | - |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Directeur/Membre du Conseil | - |
KCIF Fund Management AB | Directeur/Membre du Conseil | - |
KD Incentive AB | Directeur/Membre du Conseil | - |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Johan Dighed
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░ ░░ | ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Johan Dighed
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
DSK Hyp AG
DSK Hyp AG Major BanksFinance Provides banking services | Finance |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Promimic AB
Promimic AB Medical SpecialtiesHealth Technology Develops and markets unique coating for medical implants | Health Technology |
KCIF Fund Management AB | |
Karolinska Development AB
Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Commercial Services |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
KD Incentive AB | |
Modus Therapeutics Holding AB
Modus Therapeutics Holding AB BiotechnologyHealth Technology Develops sevuparin to treat people suffering from sickle cell disease | Health Technology |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Health Technology |
PharmNovo AB
PharmNovo AB Miscellaneous Commercial ServicesCommercial Services Operates as an biotechnology company | Commercial Services |
AnaCardio AB
AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Commercial Services |
















